1921
Volume 91, Issue 1
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645

Abstract

Abstract.

Mucosal leishmaniasis (ML) is a chronic form of tegumentary leishmaniasis, which causes destructive lesions of nasal, pharyngeal, and laryngeal mucosa. We describe a case of leishmaniasis reactivation with simultaneous cutaneous and mucosal forms in a renal transplanted patient with no history of prior leishmaniasis. Reactivation after renal transplantation was not reported in Brazil. A 67-year-old woman receiving prednisone 20 mg/day, tacrolimus 1 mg/day, and mycophenolic acid 360 mg/day presented with nose edema with erythema and cutaneous lesions. Amastigotes were identified on biopsies and the polymerase chain reaction confirmed () . The patient was treated with liposomal amphotericin B but died 3 weeks after as a result of bacterial septic shock. In conclusion, tegumentary leishmaniasis can reactivate with simultaneous cutaneous and mucosal forms in a renal transplanted patient during the immunosuppressant therapy.

Loading

Article metrics loading...

/content/journals/10.4269/ajtmh.13-0578
2014-07-02
2017-11-22
Loading full text...

Full text loading...

/deliver/fulltext/14761645/91/1/81.html?itemId=/content/journals/10.4269/ajtmh.13-0578&mimeType=html&fmt=ahah

References

  1. Reithinger R, Dujardin JC, Louzir H, Pirmez C, Alexander B, Brooker S, , 2007. Cutaneous leishmaniasis. Lancet Infect Dis 7: 581596.[Crossref]
  2. Tuon FF, Amato VS, Floeter-Winter LM, de Andrade Zampieri R, Amato Neto V, Siqueira França FO, Shikanai-Yasuda MA, , 2007. Cutaneous leishmaniasis reactivation 2 years after treatment caused by systemic corticosteroids – first report. Int J Dermatol 46: 628630.[Crossref]
  3. Oliveira-Neto MP, Mattos M, Souza CS, Fernandes O, Pirmez C, , 1998. Leishmaniasis recidiva cutis in New World cutaneous leishmaniasis. Int J Dermatol 37: 846849.[Crossref]
  4. Antinori S, Cascio A, Parravicini C, Bianchi R, Corbellino M, , 2008. Leishmaniasis among organ transplant recipients. Lancet Infect Dis 8: 191199.[Crossref]
  5. Batista MV, Pierrotti LC, Abdala E, Clemente WT, Girão ES, Rosa DR, Ianhez LE, Bonazzi PR, Lima AS, Fernandes PF, Pádua-Neto MV, Bacchella T, Oliveira AP, Viana CF, Ferreira MS, Shikanai-Yasuda MA, , 2011. Endemic and opportunistic infections in Brazilian solid organ transplant recipients. Trop Med Int Health 16: 11341142.[Crossref]
  6. Tuon FF, Gomes-Silva A, Da-Cruz AM, Duarte MI, Neto VA, Amato VS, , 2008. Local immunological factors associated with recurrence of mucosal leishmaniasis. Clin Immunol 128: 442446.[Crossref]
  7. Amato VS, Tuon FF, Siqueira AM, Nicodemo AC, Amato Neto V, , 2007. Treatment of mucosal leishmaniasis in Latin America: systematic review. Am J Trop Med Hyg 77: 266274.
  8. Tuon FF, Amato VS, Graf ME, Siqueira AM, Nicodemo AC, Amato NV, , 2008. Treatment of New World cutaneous leishmaniasis–a systematic review with a meta-analysis. Int J Dermatol 47: 109124.[Crossref]
  9. Amato VS, Tuon FF, Campos A, Bacha HA, Nicodemo AC, Neto VA, Shikanai-Yasuda MA, , 2007. Treatment of mucosal leishmaniasis with a lipid formulation of amphotericin B. Clin Infect Dis 44: 311312.[Crossref]
  10. Amato VS, Tuon FF, Camargo RA, Souza RM, Santos CR, Nicodemo AC, , 2011. Can we use a lower dose of liposomal amphotericin B for the treatment of mucosal American leishmaniasis? Am J Trop Med Hyg 85: 818819.[Crossref]
http://instance.metastore.ingenta.com/content/journals/10.4269/ajtmh.13-0578
Loading
/content/journals/10.4269/ajtmh.13-0578
Loading

Data & Media loading...

  • Received : 05 Oct 2013
  • Accepted : 16 Mar 2014

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error